Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Enumeral Biomedical Holdings, Inc. See All Filings	D	2017-05-25 16:11:50 UTC
Amount To Be Raised $3,600,000 Associated Brokers / Dealers GP NURMENKARI INC. and Katalyst Securities LLC CIK Number 0001561551 Filed Document 0001615774-17-002698 Exclusions or Exemptions 506b Accepted Date 2017-05-25 16:11:50 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Enumeral Biomedical Holdings, Inc. See All Filings	D	2016-12-14 17:54:31 UTC
Amount To Be Raised $10,774,755 Associated Brokers / Dealers Katalyst Securities LLC CIK Number 0001561551 Filed Document 0001615774-16-008920 Exclusions or Exemptions 506b Accepted Date 2016-12-14 17:54:31 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Enumeral Biomedical Holdings, Inc. See All Filings	D	2016-08-02 15:00:15 UTC
Amount To Be Raised $3,500,000 Associated Brokers / Dealers Katalyst Securities LLC CIK Number 0001561551 Filed Document 0001615774-16-006531 Exclusions or Exemptions 506b Accepted Date 2016-08-02 15:00:15 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Enumeral Biomedical Holdings, Inc. See All Filings	D	2014-08-12 00:00:00 UTC
Amount To Be Raised $21,549,510 Associated Brokers / Dealers EDI Financial, Inc. and Katalyst Securities LLC CIK Number 0001561551 Filed Document 0001615774-14-000031 Exclusions or Exemptions 506b Accepted Date 2014-08-12 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Enumeral Biomedical Holdings, Inc. See All Filings	D	2014-08-12 00:00:00 UTC
Amount To Be Raised $25,150,000 Associated Brokers / Dealers N/A CIK Number 0001561551 Filed Document 0001615774-14-000028 Exclusions or Exemptions 506b Accepted Date 2014-08-12 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity